Athersys
ATHX
#10565
Rank
NZ$1.44 M
Marketcap
NZ$0.02337
Share price
-33.50%
Change (1 day)
-98.89%
Change (1 year)

Revenue for Athersys (ATHX)

Revenue in 2023 (TTM): NZ$0.12 Million

According to Athersys's latest financial reports the company's current revenue (TTM ) is NZ$0.13 Million. In 2022 the company made a revenue of NZ$8.38 Million an increase over the revenue in the year 2021 that were of NZ$8.07 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Athersys from 2007 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) NZ$0.12 M-98.47%
2022 NZ$8.38 M3.88%
2021 NZ$8.07 M306.76%
2020 NZ$1.98 M-75.77%
2019 NZ$8.19 M-76.85%
2018 NZ$35.38 M784.01%
2017 NZ$4 M-82.92%
2016 NZ$23.44 M55.8%
2015 NZ$15.04 M4022.06%
2014 NZ$0.36 M-60.27%
2013 NZ$0.91 M-88.04%
2012 NZ$7.67 M-42.06%
2011 NZ$13.25 M14.39%
2010 NZ$11.58 M289.8%
2009 NZ$2.97 M-44.44%
2008 NZ$5.35 M25.72%
2007 NZ$4.25 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
NZ$62.26 B 44,963,650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$108.68 B 78,482,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$83.14 B 60,042,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
NZ$3.81 B 2,752,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$159.50 B 115,186,150.00%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
NZ$0.63 B 455,961.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
NZ$0.64 M 366.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$111.19 B 80,293,650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$82.26 B 59,406,251.25%๐Ÿ‡ซ๐Ÿ‡ท France